[Serial changes in plasma thromboxane and complement in ARDS--effect of the thromboxane synthetase inhibitor].
D000179:Acrylates / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D003176:Complement C3 / Q000032:analysis*; D003181:Complement C4 / Q000032:analysis*; D005260:Female; D006801:Humans; D008689:Methacrylates / Q000494:pharmacology / Q000627:therapeutic use*; D012128:Respiratory Distress Syndrome / Q000097:blood*; D013929:Thromboxane B2 / Q000097:blood*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D000179:Acrylates; D003176:Complement C3; D003181:Complement C4; D008689:Methacrylates; D013929:Thromboxane B2; D013930:Thromboxane-A Synthase; C034364:ozagrel